Abstract
The insulin-like growth factors (IGF), named for their structural homology to proinsulin, are potent mitogens involved in the endocrine, paracrine, and autocrine regulation of growth. IGF bioactivity may be altered by changes to any level of the IGF axis. The IGF axis is comprised of IGF-I and IGF-II, two IGF receptors, six IGF binding proteins (IGFBPs), and at least nine IGFBPrelated proteins (IGFBP-rPs).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Chin, E., Zhou, J., Dai, J., et al. (1994) Cellular localization of gene expression for components of the IGF ternary complex. Endocrinol. 134, 2498–2504.
Baxter, R. C. (1994) Insulin-like growth factor binding proteins in the human circulation: a review. Horm Res. 42, 140–144.
Guler, Z. S., Oh, Y., Kelley, K. M., and Rosenfield, R. G. (1989) Insulin-like growth factors I and II in healthy man: estimations of half-lives and production rates. Acta Endocrinol. 121, 753–758.
Baxter, R. C. and Daughaday, W. H. (1991) Impaired formation of the ternary insulin-like growth factor binding protein complex in patients with hypoglycemia due to nonislet cell tumors. J. Clin. Endocrinol. Metab. 73, 696–702.
Grimberg, A. and Cohen, P. (2000) Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis. J. Cell Phys. 183, 1–9.
Underwood, L. E. (1996) Nutritional regulation of IGF-1 and IGFBPs. J. Pediatr. Endocrinol. Metab. 9(u). 303–312.
Birnbacher, R., Amann, G., Breitschopf, H., et al. (1998) Cellular localization of insulin-like growth factor II mRNA in the human fetus and the placenta: detection with a digoxigenin-labeled cRNA probe and immounochemistry. Pediatr Res. 43, 614–620.
Gerrard, D. E., Okamura, C. S., Ranalletta, M. A., and Grant, A. L. (1998) Developmental expression and location of IGF-1 and IGF-2 mRNA and protein in skeletal muscle. J. Anim. Sci. 76, 1004–1011.
Ullrich, A., Gray, A., Tam, A. W., et al. (1986) Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity. EMBO J. 5, 2503–2512.
Treadway, J. L., Morrison, B. D., Goldfine, I. D., et al. (1989) Assembly of insulin-insulin-like growth factor-I hybrid receptors in vitro. J. Biol. Chem. 264, 21450.
Ludwig, T., Eggenschwiler, J., Fisher, P., et al. (1996) Mouse mutants lacking the type 2 IGF receptor (IGF-2R) are rescued from perinatal lethality in Igf2 and Igf 1r null backgrounds. Dev. Biol. 177, 517–535.
Ellis, M. J., Leav, B. A., Yang, Z., et al. (1996) Affinity for the insulin-like growth factor-II (IGF-2) receptor inhibits autocrine IGF-2 activity in MCF-7 breast cancer cells. Mol. Endocrinol. 10, 286–297.
Hwa, V., Youngman, O., and Rosenfeld, R. G. (1999) The insulin-like growth factor binding protein (IGFBP) superfamily. Endocr. Rev. 20, 761–787.
Li, Y. M., Schacher, D. H., Liu, Q., et al. (1997) Regulation of myeloid growth and differentiation by the insulin-like growth factor-I receptor. Endocrinol. 138, 362–368.
Oh, Y., Muller, H. L., Lamson, G. and Rosenfeld R. G. (1993) Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells. Cell surface binding and growth inhibition. J. Biol. Chem. 268, 14964–14971.
Yamanaka, Y., Fowlkes, J. L., Wilson, E. M., et al. (1999) Characterization of insulin-like growth factor binding protein-3 (IGFBP-3) binding to human breast cancer cells: kinetics of IGFBP-3 binding and identification of receptor binding domain on the IGFBP-3 molecule. Endocrinology 140, 1319–1328.
Mannhardt, B., Weinzimer, S.A., Wagner, M., et al. (2000) Human papillomavirus type 16 E7 oncoprotein binds and inactivates growth-inhibitory insulin-like growth factor binding protein 3. Mol. Cell Biol. 20, 6483–6495.
Jaques, G., Noll, K., Wegmann, B., et al. (1997) Nuclear localization of insulinlike growth factor binding protein 3 in lung cancer cell line. Endocrinol. 138, 1767–1770.
Schedlich, L. J., Young, T. F., Firth, S. M., and Baxter, R. C. (1998) Insulin-like growth factor-binding protein (IGFBP)-3 and IGFBP-5 share a common nuclear transport pathway in T47D human breast carcinoma cells. J. Biol. Chem. 273, 18347–18352.
Wraight, C. J., Liepe, I. J., White, P. J., et al. (1998) Intranuclear localization of insulin-like growth factor binding protein-3 (IGFBP-3) during cell division in human keratinocytes. J. Invest. Dermatol. 111, 239–2422.
Liu, B., Lee, H. Y., Weinzimer, S. A., et al. (2000) Direct functional interactions between insulin-like growth factor-binding protein-3 and retinoid X receptoralpha regulate transcriptional signaling and apoptosis. J. Biol. Chem. 275, 33607–33613.
Miyakoshi, N., Richmann, C., Kasukawa, Y., et al. (2001) Evidence that IGFbinding protein-5 functions as a growth factor. J. Clin. Invest. 107, 73–81.
Schedlich, L. J., Le Page, S. L., Firth, S. M., et al. (2000) Nuclear import of insulin-like growth factor-binding protein-3 and-5 is mediated by the importin beta subunit. J. Biol. Chem. 275, 23462–23470.
Grimberg, A. (2000) p53 and IGFBP-3: apoptosis and cancer protection. Mol. Genet. Metab. 70, 85–98.
Buckbinder, L., Talbott, R., Velasco-Miguel, S., et al. (1995) Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature 377, 646–649.
Bourdon, J. C., Deguin-Chambon, V., Lelong, J. C., et al. (1997) Further characterisation of the p53 responsive element-identification of new candidate genes for trans-activation by p53. Oncogene 14, 85–94.
Dong, G., Rajah, R., Vu, T., et al. (1997) Decreased expression of Wilms’ tumor gene WT-1 and elevated expression of insulin growth factor-II (IGF-II) and type 1 IGF receptor genes in prostatic stromal cells from patients with benign prostatic hyperplasia. J. Clin. Endocrinol. Metab. 82, 2198–2203.
Shang, Y., Baumrucker, C. R., and Green, M. H. (1999) Signal relay by retinoic acid receptors alpha and beta in the retinoic acid-induced expression of insulin-like growth factor-binding protein-3 in breast cancer cells. J. Biol. Chem. 274, 18005–18010.
Wang, D., Nagpal, M. L., Shimasaki, S., et al. (1995) Interleukin-I induces insulinlike growth factor binding protein-3 gene expression and protein production by Leydig cells. Endocrinology 136, 4049–4055.
Grimberg, A., Bingrong, L., Bannerman, P., et al. (2002) IGFBP-3 mediates p53induced apoptosis during serum starvation. Int. J. Oncol., in press.
Doolittle, R. F. (1995) The multiplicity of domains in proteins. Annu. Rev. Bio chem. 64, 287–314.
Yu, H., Spitz, M. R., Mistry, J. et al. (1999) Plasma levels of insulin-like growth factor-I and lung cancer risk: a case-control analysis. J. Natl. Cancer Inst. 91, 151–156.
Wu, X., Yu, H., Amos, C. I., Hong, W. K. and Spitz, M. R. (2000) Joint effect of insulin-like growth factors and mutagen sensitivity in lung cancer risk. J. Natl. Cancer Inst. 92, 737–743.
Chan, J.M., Stampfer, M.J., Giovanucci, E., et al. (1998) Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science 279, 563–566.
Wolk, A., Mantzoros, C.S., Andersson, O., et al. (1998) Insulin-like growth factor I and prostate cancer risk: a population-based, case-control study. J. Natl. Cancer Inst. 90, 911–915.
Ma, J., Pollack, M. N., Giovanucci, E., et al. (1999) Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. J. Natl. Cancer Inst. 91, 620–625.
Petridou, E., Dessypris, N., Spanos, E., et al. (1999) Insulin-like growth factor-I and binding protein-3 in relation to childhood leukemia. Intl. J. Cancer 80, 494–496.
Hankinson, S. E., Willett, W. C., Colditz, G. A., et al. (1998) Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet 351, 1393–1396.
Mantzoros, C. S., Tzonou, A., Signorello, L. B., et al. (1997) Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia. Br. J. Cancer 76, 1115–1118.
Cohen, P., Peehl, D. M., Stamey, T. A., et al. (1993) Elevated levels of insulin-like growth factor binding protein-2 in the serum of prostate cancer patients. J. Clin. Endocrinol. Metab. 76, 1031–1035.
Grimberg, A. and Cohen, P. (1999) Growth hormone and prostate cancer: guilty by association? J. Endocrinol. Invest. 22(u)., 64–73.
Quinn, K. A., Treston, A. M., Unsworth, E. J., et al. (1996) Insulin-like growth factor expression in human cancer cell lines. J. Biol. Chem. 271, 11477–11483.
Favoni, R. E., de Cupis, A., Ravera, F., et al. (1994) Expression and function of the insulin-like growth factor I system in human non-small cell lung cancer and normal lung cell lines. Intl. J. Cancer 56, 858–866.
Jiang, Y., Rom, W. N., Yie, T. A., et al. (1999) Induction of tumor suppression and glandular differentiation of A549 lung carcinoma cells by dominant-negative IGF-1 receptor. Oncogene 18, 6071–6077.
Lee, C. T., Wu, S., Gabrilovich, D., et al. (1996) Antitumor effects of an adenovirus expressing antisense insulin-like growth factor I receptor on human lung cancer cell lines. Cancer Res. 56, 3038–3041.
Long, L., Rubin, R., and Brodt, P. (1998) Enhanced invasion and liver colonization by lung carcinoma cells overexpressing the type 1 insulin-like growth factor receptor. Exp. Cell Res. 238, 116–121.
Kiefer, P., Jaques, G., Schoneberger, J., et al. (1991) Insulin-like growth factor binding protein expression in human small cell lung cancer cell lines. Exp. Cell Res. 192, 414–417.
Jaques, G., Kiefer, P., Schoneberger, H.J., et al. (1992) Differential expression of insulin-like growth factor binding proteins in human non-small cell lung cancer cell lines. Eur. J. Cancer 28A, 1899–1904.
Wegmann, B. R., Schoneberger, H. J., Kiefer, P. E., et al. (1993) Molecular cloning of IGFBP-5 from SCLC cell lines and expression of IGFBP-4, IGFBP-5 and IGFBP-6 in lung cancer cell lines and primary tumours. Eur. J. Cancer 29A, 1578–1584.
Noll, K., Wegmann, B. R., Havemann, K., and Jaques G. (1996) Insulin-like growth factors stimulate the release of insulin-like growth factor-binding protein-3 (IGFBP-3) and degradation of IGFBP-4 in non-small cell lung cancer cell lines. J. Clin. Endocrinol. Metab. 81, 2653–2662.
Reeve, J. G., Brinkmann, A., Hughes, S., et al. (1992) Expression of insulin-like growth factor (IGF) and IGF-binding protein genes in human lung tumor cell lines. J. Natl. Cancer Inst. 84, 628–634.
Reeve, J. G., Morgan, J., Schwander, J., and Bleehen, N. M. (1993) Role for membrane and secreted insulin-like growth factor-binding protein-2 in the regulation of insulin-like growth factor action in lung tumors. Can. Res. 53, 4680–4685.
Hochscheid, R., Jaques, G., and Wegmann, B. (2000) Transfection of human insulin-like growth factor-binding protein 3 gene inhibits cell growth and tumorigenicity: a cell culture model for lung cancer. J. Endocrinol. 166, 553–563.
Price, W. A., Moats-Staats, B. M., and Stiles, A. D. (1995) Insulin-like growth factor-I (IGF-1) regulates IGFBP-3 and IGFBP-4 by multiple mechanisms in A549 human adenocarcinoma cells. Am. J. Respir. Cell Mol. Biol. 13, 466–476.
Sueoka, N., Lee, H. Y., Wiehle, S., et al. (2000) Insulin-like growth factor binding protein-6 activates programmed cell death in non-small cell lung cancer cells. Oncogene 19, 4432–4436.
Hossenlopp, P., Seurin, D., Segovia-Quinson, B., et al. (1986) Analysis of serum insulin-like growth factor binding proteins using Western blotting: use of the method for titration of binding proteins and competitive bind studies. Anal. Biochem. 154, 138–143.
Ferry, R. J., Jr., Katz, L. E. L., Grimberg, A., et al (1999) Cellular actions of insulin-like growth factor binding proteins. Horm. Metab. Res. 31, 192–202.
Coverley, J.A. and Baxter, R.C. (1997) Phosphorylation of insulin-like growth factor binding proteins. Mol. Cell Endocrinol. 128, 1–5.
Jones, J. I, D'Ercole, J. D., Camacho-Hubner, C., and Clemmons, D. R. (1991) Phosphorylation of insulin-like growth factor (IGF)-binding protein 1 in cell culture and in vivo: Effects on affinity for IGF-I. Proc. Natl. Acad. Sci. USA 88, 7481–7485.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Coleman, C.M., Grimberg, A. (2003). Alterations in the Expression of Insulin-Like Growth Factors and Their Binding Proteins in Lung Cancer. In: Driscoll, B. (eds) Lung Cancer. Methods in Molecular Medicine™, vol 74. Humana Press, Totowa, NJ. https://doi.org/10.1385/1-59259-323-2:167
Download citation
DOI: https://doi.org/10.1385/1-59259-323-2:167
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-0-89603-985-8
Online ISBN: 978-1-59259-323-1
eBook Packages: Springer Protocols